ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag child care biotech careers industry

Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Women Make Their Mark As Top Executives In Biotech Industry
Ricki Lewis | Nov 23, 1997 | 8 min read
Being a company president-a job that entails handling day-to- day operations-or a chief executive officer (CEO)-who manages all aspects of a business-involves a unique combination of managerial skills. These roles are especially challenging for women, who are rare at corporate helms, particularly in the two-decade-old biotechnology industry. As biotech matures, the percentage of women at the top is growing. "Biotech is a relatively young industry. People are still working their way up. But we a
Special Report
lone birch tree growing sideways in a field
Amid the Terror of War, Efforts to Keep Science Alive in Ukraine
Katarina Zimmer | Mar 28, 2022 | 10+ min read
Ukrainian scientists and universities face extraordinary challenges as the Russian invasion continues.
Industry Becomes More Hospitable To The Scientist As New Mother
Ricki Lewis | Jan 8, 1995 | 6 min read
The challenge of successfully combining the demands of family and career may be easing for women scientists in industry. With increasing numbers of women opting to work in private- sector research laboratories--and in the wake of the Family and Medical Leave Act of 1993--many firms have revamped maternity-leave policies to better accommodate new parenthood and the transition back to work. The recently enacted federal law ensures workers in companies with 50 or more employees 12 weeks of unpaid,
In Times of Trouble
Kerry Grens | Aug 1, 2012 | 7 min read
Scientists share their experiences weathering extremely stressful events without letting their careers get completely derailed.
Pharmaceutical And Biotech Firms Taking On Drug-Resistant Microbes
Kathryn Brown | Jun 9, 1996 | 9 min read
Drug-Resistant Microbes As pesky pathogens continue to evolve, new technologies to combat them are emerging, spelling job opportunities for molecular biologists and chemists. OBSTINATE MICROBES: Margaret Rennels cites strains of pneumococcus resistence to two major drugs. At drug and biotech companies across the United States, scientists have set their sights on a most elusive target: drug-resistant microbes. Working in pharmaceutical- biotechnology partnerships, researchers are trying every
A Space for Children
Kerry Grens | Aug 1, 2007 | 6 min read
Industry knows that onsite childcare is good for retention. Is academia starting to catch on?
What Are The Goals And Priorities Of The Average Scientist?
Lisa Simon | May 26, 1991 | 6 min read
A 17-year-old high school student on the threshold of pursuing a scientific career worries about the public's perception of science and of what research brings to the world. A 72-year-old academic chemist is concerned that young scientists are looking to industry, rather than academia, for fulfilling work. These two people, at opposite ends of a professional lifetime, are different in many ways. But they, and three other researchers of different ages interviewed for this article, agree on many
NIH Flirts With Applied Research
Jeffrey Mervis | Feb 19, 1989 | 10 min read
New industry links profut researchers and their work, but critics fear ethics conflicts and damage to NIH's basic science mission. WASHINGTON--In 1983, Ira Pastan was chief of the molecular biology lab within the division of cancer biology and diagnosis at the National Cancer Institute. Like most of NIH's 3,100 intramural scientists, he had spent his career conducting basic research - in his case, probing gene regulation and hormone activity - in the hope of understanding how organisms funct
2020 Top 10 Innovations
The Scientist | Dec 1, 2020 | 10+ min read
From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.

Run a Search

ADVERTISEMENT